KYMR - Balance Sheet - Kymera Therapeutics, Inc.

Current Liabilities	85.7 M
Accounts Payable	7.08 M
Short-Term Debt	6.34 M
Other Current Liabilities	72.3 M
Non-Current Liabilities	95.1 M
Long-Term Debt	78.3 M
Other Non-Current Liabilities	16.8 M

Millions

	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2019	Dec-2018
ASSETS
Cash & Cash Equivalents	110.0	68.4	48.0	31.0	76.0	41.3
Short Term Investments	264.9	338.8	394.4	265.2	15.9	0
Receivables	18.8	2.5	0.1	1.4	0	0.1
Inventory	0	(12.2)	(9.0)	(163.4)	0	0
Other Current Assets	11.7	9.7	8.7	4.7	0.9	0.4
Total Current Assets	405.3	559.5	567.6	302.3	92.8	41.8
PP&E	101.1	13.3	11.9	10.8	22.1	2.2
Intangible Assets	0	0	0	0	0	0
Goodwill	0	0	0	0	0	0
Long Term Investments	61.4	152.3	125.2	162.5	1.8	0.2
Other Long Term Assets	7.9	(122.0)	(98.8)	11.5	0	0
Other Assets	0	0	0	0	0	0
Total Assets	575.8	603.1	605.9	487.2	116.7	44.2
LIABILITIES
Accounts Payable	7.1	4.3	4.0	4.4	3.3	2.1
Short Term Debt	6.3	7.9	7.2	6.5	3.4	0.3
Other Current Liabilities	34.4	23.9	19.6	7.2	4.6	2.3
Total Current Liabilities	85.7	63.3	101.0	110.6	34.6	4.7
Long Term Debt	78.3	26.8	28.7	29.5	17.8	0.4
Deferred Tax Income	0	0	(53.7)	0	0	0
Other Liabilities	0	(13.1)	(14.3)	(14.6)	109.1	73.6
Total Liabilities	180.8	113.0	146.3	203.3	191.1	78.7
EQUITY
Common Stock	6 K	6 K	5 K	4 K	0	0
Retained Earnings	(530.8)	(383.8)	(229.0)	(128.8)	(76.5)	(35.2)
Other Accumulative Comprehensive Income/Loss	(0.6)	(4.9)	(0.7)	(0.1)	6 K	0
Total Equity	395.0	490.2	459.6	283.9	(74.4)	(34.4)
Total Liabilities and Equity	575.8	603.1	605.9	487.2	116.7	44.2
SHARES OUTSTANDING
Common Shares Outstanding	58.4	53.9	48.0	17.3	44.5	44.5

Free